NABP Accreditation for Pharmacies & Drug Distributors: A Practical Guide

As pharmacy models become increasingly digital, distributed, and complex, accreditation can play an important role in demonstrating compliance, quality, and operational readiness. Many pharmacies wonder whether NABP accreditation is the right fit for them and how to obtain accreditation. 

It’s key to emphasize that NABP is not a single program, and it is not universally required. It is a portfolio of distinct, purpose-built credentials, each tied to a specific business model. Each is also governed by its own eligibility criteria, standards, and renewal cycle. Choosing the wrong program, or assuming accreditation is optional when a state board or payer contract says otherwise, carries real operational and financial consequences. 

Since NABP offers several accreditation programs built for different business models, understanding which one applies to your organization, and what the process involves, is the first step toward preparing effectively. This guide is meant to help you understand what NABP accreditation covers, which program fits which business model, what the process involves from application to reaccreditation, and where organizations most commonly underestimate the scope of the work.

Not every reader needs to work through the full guide before acting. Restore Health Consulting's consultants work with pharmacies and drug distributors on NABP accreditation planning and preparation, and can generally tell you within a single conversation which programs apply to your business and what preparing for them will require. Contact us to review your situation and schedule a free introductory consultation.

What You Need to Know

  • NABP offers multiple accreditation programs, each designed for different pharmacy and healthcare business models.

  • Accreditation requirements vary by program, making it important to establish eligibility and the appropriate accreditation pathway before beginning preparation.

  • The accreditation process involves eligibility, standards review, documentation, inspection or survey, remediation, and ongoing compliance.

  • Digital pharmacy and telehealth models bring additional operational and regulatory considerations that should be addressed during accreditation readiness planning.

  • Pharmacies and drug distributors can benefit from early gap analysis and structured preparation before an NABP application, survey, or inspection.

What does NABP stand for?

NABP stands for the National Association of Boards of Pharmacy. Founded in 1904, NABP is a 501(c)(3) nonprofit association that supports the state boards of pharmacy, not a government agency in its own right. Its member boards include all 50 US states, the District of Columbia, Guam, Puerto Rico, the Virgin Islands, and a number of Canadian provincial boards, organized into eight geographic districts.

NABP's core functions extend well beyond accreditation. The association administers the NAPLEX licensure examination, operates pharmacist license transfer services, maintains a disciplinary clearinghouse used by state boards, and runs the .Pharmacy domain verification program. Accreditation sits alongside these functions as one of several tools NABP uses to support its member boards' regulatory oversight of pharmacy practice and the drug supply chain.

Among its programs are accreditation pathways for pharmacies, digital pharmacy businesses, and drug distributors. The appropriate accreditation depends on the organization's activities and business model.

What is the purpose of the NABP?

NABP's stated mission is to serve as the independent, international, and impartial association that assists its member boards in protecting the public health. 

In practice, this means NABP functions primarily as a regulatory support and verification body on behalf of state licensing authorities, not as a clinical quality organization in the mold of URAC or The Joint Commission. Its accreditation programs are built around verifying legal operation, licensure standing, supply chain security, and compliance with federal and state pharmacy law, which is a different orientation than accreditation frameworks built around measured clinical outcomes.

That distinction matters when an organization is deciding between accreditation bodies, or deciding whether to pursue more than one. NABP accreditation answers the question "Does this pharmacy or distributor meet defined standards for safe, compliant, and secure operation?" It does not, by itself, answer the question "Is this pharmacy delivering superior clinical outcomes?", which is the domain URAC and similar bodies are built to address. 

For example, a specialty pharmacy may pursue NABP Specialty Pharmacy Accreditation to meet a specific network or regulatory requirement, while pursuing a separate clinical accreditation when a payer, health plan, or other contracting organization requires evidence of clinical quality.

Is NABP Accreditation Required?

The answer depends on the business model and the states in which the organization operates. Although NABP accreditation is generally voluntary, it is required by specific state laws for wholesale distributors and by major tech and payment platforms for online advertising and card processing.

This places NABP accreditation on a spectrum from strictly voluntary to functionally mandatory:

Required by state law. Some states require wholesale drug distributors to obtain specific accreditation as a condition of licensure. Indiana, for example, requires wholesale drug distributors of legend drugs to obtain and maintain NABP Drug Distributor Accreditation (DDA). 

Other states take a broader approach. Maryland, for example, requires certain out-of-state wholesale distributors to be accredited by a Board-recognized accrediting program or to qualify for reciprocity. DDA is one of the Board-recognized accreditation options, but it is not the only pathway. This distinction is important: a state may require accreditation without requiring accreditation specifically from NABP. 

Required for certain government programs. Some NABP accreditation programs are relevant to participation in federal healthcare programs. For example, NABP’s durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) Pharmacy Accreditation is among the pathways recognized by the Centers for Medicare & Medicaid Services (CMS) for pharmacies seeking to gain Medicare Part B billing privileges for DMEPOS services.  Home Infusion Therapy Pharmacy Accreditation carries the same CMS approval and the same practical requirement for pharmacies billing Medicare for home infusion services.

Required by contract, not by law. Specialty Pharmacy Accreditation is not a legal mandate anywhere, but it is a contractual requirement for participation in Optum Rx's Specialty Pharmacy Network. A pharmacy can operate a specialty dispensing business without it; it cannot bill Optum Rx as a network specialty pharmacy without it.

Required functionally by digital platforms and payment processors. Healthcare Merchant Accreditation is not required by any state board, but Google, Bing, Visa, and Mastercard reference it in their own certification requirements for pharmacy merchants and telemedicine providers running paid digital advertising or processing card-not-present transactions. Without it, a digital pharmacy's ability to advertise or process payment is constrained by forces entirely outside NABP's own authority.

Recognized, and increasingly expected, by state boards. Digital Pharmacy Accreditation is not federally mandated, but it is recognized or required by more than 20 state boards of pharmacy, and some boards have begun treating NABP accreditation or an equivalent credential as a condition of licensure for online pharmacy operations.

The practical takeaway for operators: "voluntary" and "optional" are not the same thing. A program can be technically voluntary while being commercially or operationally non-negotiable for a given business model.

Importantly, NABP recommends contacting the state boards of pharmacy directly to confirm licensing requirements and accreditation recognition.

Accreditation should also be distinguished from pharmacy licensure and regulatory compliance. NABP accreditation does not replace a state pharmacy license or other applicable legal and regulatory requirements.

Which NABP Accreditation Does Your Pharmacy or Business Need? 

NABP administers eight active accreditation programs across three broad categories: pharmacy accreditations, online accreditations, and distributor accreditations. Some business models require more than one.

Table 1

Business Model

Relevant NABP Program
Community pharmacy offering advanced clinical services (MTM, immunizations, wellness screenings)

Community Pharmacy Accreditation
Compounding pharmacy (sterile and/or non-sterile)

Compounding Pharmacy Accreditation
Digital/online pharmacy with an interactive website

Digital Pharmacy Accreditation
Pharmacy providing DMEPOS billing Medicare

DMEPOS Pharmacy Accreditation
Home infusion pharmacy billing Medicare

Home Infusion Therapy Pharmacy Accreditation
Specialty pharmacy, particularly for Optum Rx network participation

Specialty Pharmacy Accreditation
Wholesale drug distributor or third-party logistics provider

Drug Distributor Accreditation
OTC medical device distributor (prescription diagnostic devices)

OTC Medical Device Distributor Accreditation
Health or health-adjacent business needing card-processing and ad-platform certification

Healthcare Merchant Accreditation

A digital compounding pharmacy that ships nationally, for example, may need Compounding Pharmacy Accreditation for its dispensing operations, Healthcare Merchant Accreditation to obtain its .Pharmacy domain, and Digital Pharmacy Accreditation to operate its patient-facing website, in that sequence, since Healthcare Merchant Accreditation and an active .Pharmacy domain are prerequisites for the Digital Pharmacy application.

Therefore, the table provides a starting point, but eligibility and accreditation requirements should be confirmed with NABP based on the organization's specific structure and activities. 

NABP Accreditation Process 

While each program has its own standards and criteria, most NABP accreditations follow a broadly consistent eight-step pathway.

Step 1: Determine eligibility. Confirm licensure status in every jurisdiction of operation, resident pharmacist-in-charge requirements, minimum operating history (commonly 30 days of active operation for digital pharmacy applicants), and any prerequisite accreditations. For drug and OTC medical device distributors, NABP recommends reviewing the Distributor Accreditation Ineligibility Matrix, which can help facilities self-assess baseline eligibility requirements for accreditation.

Step 2: Review accreditation standards. Each program publishes its own standards document. For Drug Distributor Accreditation, this includes Good Distribution Practices and Drug Supply Chain Security Act (DSCSA) requirements. For compounding pharmacies, standards are built around alignment with USP <795>, <797>, and <800> and Section 503A of the Federal Food, Drug, and Cosmetic Act, and applicants must also complete a Verified Pharmacy Program (VPP) inspection within six months of their application date; see the VPP section in the FAQs below for how this inspection differs from accreditation itself.

Step 3: Prepare policies, procedures, records, and supporting documentation. This is typically the most time-intensive step and the most common source of delay. Standard operating procedures, staff training and competency records, licensure documentation, and quality assurance program documentation all need to exist in a form that maps directly to the applicable standards, not simply in a form that satisfies internal operations.

Step 4: Submit the application. Applications are submitted through NABP's business e-Profile system, which also serves as the account of record for renewals and compliance reviews.

Step 5: Complete the required inspection or survey. Most programs require an announced on-site survey or inspection. Drug Distributor Accreditation requires a separate Supply Chain Inspection (SCI) as a distinct phase preceding the DDA application itself.

Step 6: Address deficiencies, if applicable. Findings from the survey or document review are returned to the applicant with a defined window, commonly 90 days, to submit corrective documentation before a decision is finalized.

Step 7: Receive accreditation. Most NABP accreditations are issued for a three-year term.

Step 8: Maintain accreditation and complete ongoing reviews. Nearly every program requires annual compliance reviews in years two and three of the term, including a renewal submission, updated supporting documentation, confirmation of continued standards compliance, and payment of the applicable participation fee. Reaccreditation begins again before the three-year term expires.

How Long Does the Process Take?

On average, 4–9 months, depending on the specific program and company readiness. For example, for Specialty Pharmacy Accreditation, NABP mentions 6–9 months, but they note it may take less or more time depending on the pharmacy’s preparedness and familiarity with other accreditations. 

NABP Digital Pharmacy Accreditation Process

The process for Digital Pharmacy Accreditation layers additional prerequisites onto the general pathway above:

  1. Obtain Healthcare Merchant Accreditation and register an active .Pharmacy domain for each website. NABP will not consider a Digital Pharmacy application from an applicant without both in place prior to applying.

  2. Confirm eligibility: current licensure in every jurisdiction served, at least 30 days of active operation, at least one dispensed prescription, a pharmacist-in-charge in full and actual authority over operations and compliance, and predominantly human (rather than veterinary) prescription volume.

  3. Review the current Standards Overview to confirm the program's scope matches the business.

  4. Create a business e-Profile account, which can take up to three business days to process.

  5. Gather supporting documentation, including licensure records, policies and procedures, and website compliance documentation.

  6. Submit the application, which may bundle multiple websites or multiple accreditation programs under a single e-Profile account.

Once approved, Digital Pharmacy Accreditation runs for a three-year term with annual compliance reviews in years two and three, followed by full reaccreditation before expiration.

NABP Drug Distributor Accreditation Process

Drug Distributor Accreditation runs on a distinct two-phase structure that operators should plan for from the outset:

Phase 1: Supply Chain Inspection (SCI). This is a prerequisite inspection of the facility conducted by NABP surveyors, separate from and preceding the DDA application itself. It is assessed through a separate application fee, inspection fee, and eligibility fee.

Phase 2: DDA application. Once the SCI is complete, the facility submits the DDA application itself, which is reviewed against the current Drug Distributor Accreditation Criteria, covering licensure verification, security and operational best practices, and DSCSA product tracing, verification, and trading partner requirements.

Nontraditional business models, including third-party logistics providers and virtual wholesale distributors, are addressed separately within the criteria and carry their own eligibility conditions. A virtual manufacturer, for instance, must distribute through an NABP-accredited third-party logistics provider and transfer ownership only from a licensed location. Organizations operating outside the standard wholesale distributor model should confirm which category they fall into before beginning the SCI, since it affects both eligibility and documentation requirements.

The full DDA cycle, from initial Supply Chain Inspection through accreditation award, commonly runs six to nine months. Documentation gaps, multi-facility complexity, and corrective action following the on-site inspection can extend the timeline.

How Does DDA Apply to 503B Outsourcing Facilities?

503B outsourcing facilities are a distinct business model within NABP's Drug Distributor Accreditation program. NABP specifically includes outsourcing facilities among the nontraditional business models subject to additional DDA criteria.

A 503B seeking DDA must meet specific eligibility requirements, including registration with FDA as an outsourcing facility, compounding at least one sterile preparation, compliance with Section 503B, and a qualifying state or federal regulatory inspection demonstrating compliance with applicable CGMP and federal requirements. NABP also requires the facility to have no open FDA actions or to demonstrate ongoing communication with FDA toward resolution.

DDA may be relevant for 503Bs with significant distribution activities, particularly those supplying compounded drugs across multiple jurisdictions or operating within more complex supply-chain models. The accreditation provides a framework for evaluating distribution-related controls alongside the facility's existing regulatory obligations.

The applicability of DDA depends on the facility's business model, distribution activities, and state requirements. A 503B should evaluate these factors before determining whether DDA is appropriate.

NABP Accreditation Cost

Cost varies substantially by program and should be budgeted in two distinct categories: NABP's own fees, and the internal or consulting cost of preparing for the application and inspection.

Healthcare Merchant Accreditation: Approximately $2000 in the first year for a single website. This includes the first-year application fee ($1,075) and the .Pharmacy domain (~$1,000, purchased through a third-party registrar separate from NABP). Annual participation is $1,075 after year one, excluding domain fees. The fee scales with the number of websites, so an organization enrolling three websites under one application pays $3,225 rather than $1,075.

Drug Distributor Accreditation: DDA uses a two-phase fee structure. The prerequisite Supply Chain Inspection carries its own application, inspection, and eligibility fees, followed by the DDA application and applicable participation fees. NABP does not publish a complete itemized DDA fee schedule publicly; applicants should confirm current Phase 1 and Phase 2 fees through their Business e-Profile before budgeting. Additional charges may apply, including fees for extended inspection time or changes to the accreditation scope after submission. Internal preparation and third-party consulting are separate costs and can vary substantially based on documentation maturity, facility complexity, and the number of sites involved. 

DMEPOS Pharmacy Accreditation: Current fees should be confirmed directly with NABP, as the fee structure has changed over time and historical figures may no longer apply.

Plan for both the accreditation fee and the cost of getting accreditation-ready. Fee schedules are revised periodically, so organizations should confirm current fees directly on the relevant NABP accreditation program page  For organizations with gaps in policies, documentation, training, or operational processes, readiness work can represent a larger and more variable portion of the total accreditation cost.

NABP Digital Pharmacy Accreditation

Digital Pharmacy Accreditation, formerly known as VIPPS (Verified Internet Pharmacy Practice Sites), has operated since 1999 and is NABP's accreditation program for pharmacies operating websites that offer at least one interactive pharmacy practice component, such as new, refill, or transfer prescription requests, patient counseling or communication, or a patient or prescriber portal.

The program emerged in response to a documented problem with unsafe and noncompliant online pharmacy operations. NABP's own Internet Drug Outlet Identification Program report from April 2015 found that 96% of nearly 11,000 online drug outlets reviewed were operating out of compliance with state or federal pharmacy laws, or with NABP's own patient safety and practice standards. Findings ranged from improper prescription verification to the distribution of unapproved or foreign drug products. Digital Pharmacy Accreditation provides a standardized way for patients, payers, and other stakeholders to identify online pharmacies that have been assessed against NABP's accreditation standards.

Standards cover licensure and policy maintenance, compliance with state and federal prescription drug and OTC regulations, privacy and security of patient information, pharmacist-patient communication, drug storage and shipping, quality improvement programming, and reporting obligations to NABP. NABP reports that over 80 Digital Pharmacy-accredited companies serve millions of patients today. Organizations verifying a specific pharmacy's current status should consult NABP's own directory of accredited digital pharmacies, where current accreditation status can be confirmed.

Relevance of NABP Accreditation in the Digital & Telehealth Age

The growth of telehealth-adjacent pharmacy models, direct-to-consumer prescribing platforms, and asynchronous online consultation has made Digital Pharmacy Accreditation more operationally relevant, not less. Multistate licensure alone does not address every requirement facing these businesses. A pharmacy shipping prescriptions across state lines must be licensed in each state where required, but licensure does not by itself demonstrate that the operation has been assessed against additional standards for privacy, security, pharmacy practice, and online operations.

This is where Digital Pharmacy Accreditation serves a distinct purpose. Per NABP's own program materials, it is recognized or required by more than 20 state boards of pharmacy. Completing the Healthcare Merchant Accreditation as its prerequisite satisfies the advertising requirements of platforms including Google, Bing, Yahoo, Reddit, TikTok, Snapchat, and Twitter, as well as Visa's and Mastercard's certification and monitoring requirements for card-not-present pharmacy and telemedicine transactions. 

For digital-first and telehealth-adjacent pharmacy businesses, the practical implication is significant: accreditation can affect access to advertising, payment processing, state licensure, and payer or network relationships at the same time. It should therefore be evaluated as part of the business model and market-entry strategy, not simply as an optional compliance credential.

LegitScript: A Second Layer of Oversight Operators Should Not Overlook 

NABP is not the only entity standing between a digital pharmacy and the platforms it depends on to advertise and get paid. LegitScript, a privately held compliance and monitoring company, occupies an adjacent but distinct role. Where NABP is a nonprofit association working with state pharmacy boards, LegitScript is a commercial certification and intelligence firm that evaluates online pharmacies, telemedicine providers, and other healthcare merchants against its own standards. It also continuously monitors the market for noncompliant operators and provides intelligence to regulators, payment networks, and advertising platforms. 

For operators, the distinction is primarily commercial. Visa and Mastercard recognize LegitScript as a verification body for card-not-present pharmacy and pharmaceutical merchants, while LegitScript Healthcare Certification is used by major advertising platforms including Google, Meta, Microsoft Ads, TikTok, LinkedIn, and Netflix. 

The requirements are not interchangeable across platforms. Google's advertising policy accepts LegitScript Healthcare Merchant Certification or NABP's VIPPS/.Pharmacy Verified Websites Program as alternative paths to Google's pharmacy certification. Meta's advertising policy, however, specifically requires active LegitScript certification for online pharmacies and telehealth providers. A pharmacy with NABP accreditation but no LegitScript certification may therefore qualify for Google advertising while remaining ineligible to advertise on Meta. 

This means that a pharmacy holding only NABP Digital Pharmacy or Healthcare Merchant Accreditation, with no LegitScript certification, can find itself able to advertise on Google but locked out of Meta entirely.

LegitScript certification also carries separate application, monitoring, and renewal costs and requires ongoing compliance with its certification standards. For pharmacies building a digital accreditation strategy, NABP and LegitScript should therefore be evaluated as parallel requirements rather than interchangeable credentials. The appropriate combination depends on the states in which the pharmacy operates, the advertising platforms it plans to use, and how it processes payments. 

NABP Accreditation and GLP-1 Compounding 

GLP-1 compounding has become an important compliance consideration for pharmacies pursuing or maintaining NABP accreditation as FDA shortage determinations, compounding policies, and enforcement priorities have changed since 2024. With semaglutide and tirzepatide no longer on the FDA drug shortage list, pharmacies cannot assume that practices permitted during the shortage period remain appropriate today.

For pharmacies pursuing or maintaining NABP accreditation, the practical issue is ongoing regulatory alignment. The first question is which statutory framework applies. A 503A pharmacy and a 503B outsourcing facility operate under different requirements for compounding, sourcing, and the use of bulk substances. Pharmacies also need to monitor current FDA requirements and reassess affected products and processes as those requirements change.

For digital and telehealth pharmacies, the review should extend beyond the compounding process itself to how compounded GLP-1 products are described, marketed, and presented on the website. Product claims, representations about FDA approval, and comparisons with commercially manufactured products can create additional compliance concerns.

GLP-1 compliance should therefore be treated as an ongoing accreditation-maintenance issue, not a one-time review. Pharmacies operating in this space should have a defined process for monitoring regulatory changes, reassessing affected products, processes, sourcing, and marketing, and documenting the resulting decisions.

FAQs

Does Each Location Need Its Own Accreditation?

There is no single answer. NABP itself frames this as program-dependent rather than uniform across its portfolio: some accreditations are location-specific, and others are corporate accreditations that can extend across common ownership. Digital Pharmacy Accreditation, for example, requires Healthcare Merchant Accreditation and an active .Pharmacy domain for each website, which functionally means each distinct web property carries its own accreditation footprint even under one corporate parent. Other programs allow a multi-location organization to accredit under a single corporate structure with location-level documentation folded into one application.

Confirm the location scope before building the application. Getting this wrong can affect the application structure, documentation requirements, inspection scope, cost, and timeline.

How Does the Verified Pharmacy Program (VPP) Relate to Accreditation?

The Verified Pharmacy Program (VPP) is an inspection program, not an accreditation. NABP conducts the inspection and provides the resulting information to state boards, but it does not issue a “passed” or “compliant” determination or make the licensing decision. Each state board remains responsible for determining whether a pharmacy meets its own licensing requirements.

VPP was designed to streamline pharmacy inspections for organizations seeking licensure in multiple states. Rather than each state board conducting its own inspection, a pharmacy can undergo a uniform NABP inspection, with the resulting report and related information made available to participating state boards.

VPP also intersects directly with NABP accreditation:

  • Compounding Pharmacy Accreditation: A VPP inspection is a prerequisite for applicants and must be completed within the required timeframe before the accreditation application.

  • Drug Distributor Accreditation: VPP may also be relevant to certain distributor licensing and eligibility requirements, depending on the business model and applicable state requirements.

The key distinction is simple: VPP supports state licensing through inspection and information sharing; NABP accreditation evaluates an organization against defined accreditation standards. A pharmacy can undergo a VPP inspection without holding NABP accreditation, while a pharmacy pursuing Compounding Pharmacy Accreditation will encounter VPP as part of the accreditation process.

Is NABP the Same as NCPDP?

No. NABP and NCPDP (the National Council for Prescription Drug Programs) are separate organizations with different functions.

The confusion largely comes from the term “NABP number.” What is still commonly called an NABP number is formally the NCPDP Provider Identification Number, a seven-digit identifier used by pharmacies when communicating with third-party payers, including insurers and PBMs, for claims processing and reimbursement. NCPDP, not NABP, issues this identifier.

A pharmacy may have several different identifiers, each serving a different purpose:

  • NCPDP Provider ID: Used for pharmacy claims, billing, and reimbursement.

  • National Provider Identifier (NPI): A 10-digit identifier assigned through the CMS NPI system and used for HIPAA-covered electronic transactions.

  • NABP business e-Profile ID: Used within NABP's system for activities such as accreditation applications, inspections, and continuing education tracking.

NABP does not issue the NCPDP Provider ID. The two organizations are connected primarily through historical terminology and the pharmacy industry's use of the term “NABP number,” not because they perform the same function.

Practical takeaway: If a payer, PBM, accreditation program, or application asks for an identifier, confirm which one is required. NCPDP Provider ID, NPI, and NABP e-Profile ID are not interchangeable.

NABP Accreditation Client Case Studies

Restore Health Consulting has completed more than 100 projects nationwide over five years, providing end-to-end gap analyses and operational assessments for sterile compounding facilities preparing for NABP, State Board, and internal quality inspections.

Our work combines regulatory and compliance expertise with an understanding of how pharmacy operations function in practice, helping facilities identify gaps, address deficiencies, and prepare for successful inspections and accreditation.

16-Fold Increase In Sustainable Sterile Compounding Capacity + NABP accreditation

RHC performed a comprehensive operational and facility workflow assessment for a licensed sterile compounding pharmacy seeking to increase capacity.

The assessment identified opportunities to improve workflow and operational efficiency, ultimately supporting a 16-fold increase in sustainable sterile compounding capacity without expanding footprint while helping the pharmacy achieve NABP accreditation.

Read the full case study →

503A Secures NABP Accreditation After Deficiencies

RHC performed a comprehensive gap analysis for a 503A pharmacy following identified accreditation deficiencies. We helped the client evaluate the findings, develop an appropriate response, and prepare the required submission to NABP.

The pharmacy successfully obtained accreditation without requiring a reinspection.

Read the full case study →

Comprehensive Gap Analyses for 503A Sterile Compounding Facilities

RHC provides comprehensive gap analyses for 503A sterile compounding facilities preparing for NABP and State Board inspections.

Using a four-phase methodology, our team assesses facilities ranging from hospital Category 1 operations to high-risk sterile-to-nonsterile Category 3 facilities, helping clients identify compliance gaps and prepare their operations and documentation for inspection.

Clients have used this process to approach NABP and State Board inspections with greater clarity, confidence, and operational readiness.

Learn more about RHC's gap analysis methodology →

Restore Health Consulting Support for NABP Accreditation

Restore Health Consulting helps pharmacies and drug distributors prepare for NABP accreditation through structured readiness assessments, regulatory gap analyses, documentation development, survey preparation, and corrective action planning.

Our consultants evaluate accreditation requirements alongside the organization's current operations, policies, documentation, personnel practices, and quality systems. This provides leadership with a clear view of existing gaps, priority actions, and the work required to achieve and maintain accreditation readiness.

Our accreditation support includes:

  • Accreditation readiness assessments and gap analyses to identify deficiencies against applicable NABP standards

  • Accreditation project planning and implementation with defined priorities, responsibilities, and timelines

  • Policy and procedure development and revision aligned with applicable accreditation standards and operational requirements

  • Quality management, emergency preparedness, patient management, operations, and staff training programs

  • Survey and inspection preparation, including staff training and readiness assessments

  • Coordination with accreditation organizations throughout the application, survey, and remediation process

  • Corrective action plans addressing identified deficiencies and trends from ongoing internal monitoring

  • Reaccreditation and ongoing compliance support to maintain readiness throughout the accreditation cycle

Our consultants bring extensive auditing and regulatory experience across pharmacy and sterile compounding operations. We assess how requirements are reflected in daily practice and supporting documentation, helping organizations address gaps before they become accreditation findings.

Prepare for NABP Accreditation

Whether your organization is pursuing NABP accreditation, expanding into digital pharmacy or telehealth, responding to accreditation deficiencies, or preparing for reaccreditation, Restore Health Consulting can provide the assessment and compliance support needed to move forward with a clear plan.

Contact Restore Health Consulting to discuss your accreditation requirements and build a readiness strategy tailored to your organization.

Book an Exploratory Call

References

Disclaimer: This article is intended to provide general information on U.S. compounding. It should not be construed as legal, regulatory, or medical advice. Readers are encouraged to consult an attorney for guidance specific to their circumstances.    

503Ana AleksicNABP Accreditation